NCT01649050View on ClinicalTrials.gov

Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Muscle Spasticity Due to Multiple Sclerosis
Interventions
DRUG

BGG492

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY